2011
DOI: 10.1016/j.jmv.2011.05.004
|View full text |Cite
|
Sign up to set email alerts
|

Maladie de Kikuchi et lupus : à propos d’une observation, revue de la littérature et intérêt de la tomographie par émission de positons au 18F-Fluorodésoxyglucose (TEP–TDM FDG)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2015
2015

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“… France (Frikha et al 2008 ) 30 year old Female Mixed connective tissue disease for 8 years ANA, anticardiolipin Lymphadenitis resolved with corticosteroid therapy. Taiwan (Chen and Lan 1998 ) 4 cases All female Ages 21–35 years old SLE for 8 days to 2 years Ribosomal-P antibodies (1 case) RNP (1 case) None (2 cases) No life-threatening sequelae France (Abraham et al 2011 ) 35 year old Female Overlap syndrome for 12 years Antiphospholipid antibodies Lymphadenitis resolved with corticosteroid therapy. Sabah (Bachi 2002 ) 27 year old Female SLE – systemic symptoms for 2 months ANA, anti-Ro, anti-La at onset of lymphadenitis Complete remission with corticosteroid therapy.…”
Section: Discussionmentioning
confidence: 99%
“… France (Frikha et al 2008 ) 30 year old Female Mixed connective tissue disease for 8 years ANA, anticardiolipin Lymphadenitis resolved with corticosteroid therapy. Taiwan (Chen and Lan 1998 ) 4 cases All female Ages 21–35 years old SLE for 8 days to 2 years Ribosomal-P antibodies (1 case) RNP (1 case) None (2 cases) No life-threatening sequelae France (Abraham et al 2011 ) 35 year old Female Overlap syndrome for 12 years Antiphospholipid antibodies Lymphadenitis resolved with corticosteroid therapy. Sabah (Bachi 2002 ) 27 year old Female SLE – systemic symptoms for 2 months ANA, anti-Ro, anti-La at onset of lymphadenitis Complete remission with corticosteroid therapy.…”
Section: Discussionmentioning
confidence: 99%